| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.909 | 0 | 0.93 | Anabolic | 0.93 0 DBMET00851 0.477 0.001 DBMET00674 | DBMET00851 | |
| 0.868 | 0.002 | 0.976 | Androgen antagonist | 0.976 0.001 DBMET00851 0.836 0.002 DBMET00674 | DBMET00851 | |
| 0.866 | 0.001 | 0.968 | Androgen agonist | 0.968 0.001 DBMET00851 0.869 0.001 DBMET00674 | DBMET00851 | |
| 0.847 | 0.01 | 0.863 | Antiinflammatory | 0.863 0.008 DBMET00851 0.82 0.013 DBMET00674 | DBMET00851 | |
| 0.751 | 0.002 | 0.858 | Estrogen receptor alpha antagonist | 0.858 0.002 DBMET00851 0.58 0.003 DBMET00674 | DBMET00851 | |
| 0.737 | 0.004 | 0.771 | Hypoxia-inducible factor 1 alpha inhibitor | 0.771 0.003 DBMET00851 0.627 0.006 DBMET00674 | DBMET00851 | |
| 0.713 | 0.028 | 0.73 | Apoptosis agonist | 0.73 0.026 DBMET00851 0.666 0.036 DBMET00674 | DBMET00851 | |
| 0.691 | 0.009 | 0.959 | Aldehyde oxidase inhibitor | 0.959 0.002 DBMET00851 0.894 0.003 DBMET00674 | DBMET00851 | |
| 0.68 | 0.001 | 0.838 | Glucocorticoid antagonist | 0.838 0.001 DBMET00851 0.507 0.002 DBMET00674 | DBMET00851 | |
| 0.682 | 0.003 | 0.712 | Estrogen antagonist | 0.712 0.003 DBMET00851 0.505 0.004 DBMET00674 | DBMET00851 | |
| 0.66 | 0.003 | 0.795 | Estrogen agonist | 0.795 0.002 DBMET00851 0.685 0.003 DBMET00674 | DBMET00851 | |
| 0.606 | 0.003 | 0.843 | Aromatase inhibitor | 0.843 0.001 DBMET00851 0.708 0.002 DBMET00674 | DBMET00851 | |
| 0.603 | 0.002 | 0.702 | Lipocortins synthesis antagonist | 0.702 0.001 DBMET00851 0.613 0.002 DBMET00674 | DBMET00851 | |
| 0.585 | 0.033 | 0.813 | Transcription factor NF kappa B inhibitor | 0.813 0.012 DBMET00851 0.673 0.024 DBMET00674 | DBMET00851 | |
| 0.513 | 0.003 | 0.514 | Sodium/bile acid cotransporter inhibitor | 0.514 0.003 DBMET00851 0.475 0.005 DBMET00674 | DBMET00851 | |
| 0.513 | 0.004 | 0.555 | Estrogen receptor beta antagonist | 0.555 0.003 DBMET00851 0.36 0.004 DBMET00674 | DBMET00851 | |
| 0.496 | 0.002 | 0.554 | Estrogen receptor alpha agonist | 0.554 0.002 DBMET00851 0.415 0.003 DBMET00674 | DBMET00851 | |
| 0.504 | 0.032 | 0.595 | Immunosuppressant | 0.595 0.014 DBMET00851 0.553 0.02 DBMET00674 | DBMET00851 | |
| 0.465 | 0.002 | 0.871 | Progesterone antagonist | 0.871 0.001 DBMET00851 0.779 0.001 DBMET00674 | DBMET00851 | |
| 0.444 | 0.005 | 0.444 | Growth factor agonist | 0.19 0.074 DBMET00851 | ||
| 0.387 | 0.003 | 0.692 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.692 0.002 DBMET00851 0.136 0.004 DBMET00674 | DBMET00851 | |
| 0.346 | 0.009 | 0.346 | Acetylcholine M1 receptor antagonist | 0.224 0.033 DBMET00851 0.136 0.089 DBMET00674 | ||
| 0.34 | 0.004 | 0.558 | Mineralocorticoid receptor antagonist | 0.558 0.002 DBMET00851 0.284 0.004 DBMET00674 | DBMET00851 | |
| 0.365 | 0.03 | 0.413 | Nitric oxide antagonist | 0.39 0.027 DBMET00851 0.413 0.024 DBMET00674 | DBMET00674 | |
| 0.321 | 0.004 | 0.443 | Estrogen receptor beta agonist | 0.443 0.003 DBMET00851 0.258 0.004 DBMET00674 | DBMET00851 | |
| 0.304 | 0.002 | 0.597 | Progesterone agonist | 0.597 0.001 DBMET00851 0.336 0.001 DBMET00674 | DBMET00851 | |
| 0.307 | 0.016 | 0.307 | Bone formation stimulant | 0.239 0.027 DBMET00851 0.223 0.03 DBMET00674 | ||
| 0.266 | 0.004 | 0.332 | Arachidonic acid antagonist | 0.332 0.001 DBMET00851 0.29 0.002 DBMET00674 | DBMET00851 | |
| 0.296 | 0.044 | 0.296 | Antimitotic | |||
| 0.269 | 0.02 | 0.4 | Antipruritic | 0.4 0.006 DBMET00851 0.251 0.024 DBMET00674 | DBMET00851 | |
| 0.269 | 0.025 | 0.48 | Interferon gamma antagonist | 0.48 0.007 DBMET00851 0.425 0.009 DBMET00674 | DBMET00851 | |
| 0.252 | 0.01 | 0.252 | GABA receptor agonist | 0.123 0.054 DBMET00851 | ||
| 0.255 | 0.019 | 0.255 | Acetylcholine antagonist | 0.142 0.055 DBMET00851 | ||
| 0.255 | 0.02 | 0.255 | Cholinergic antagonist | 0.144 0.056 DBMET00851 | ||
| 0.244 | 0.011 | 0.244 | Alpha 2c adrenoreceptor antagonist | |||
| 0.273 | 0.041 | 0.694 | Anesthetic general | 0.694 0.003 DBMET00851 0.455 0.011 DBMET00674 | DBMET00851 | |
| 0.23 | 0.003 | 0.406 | RNA-directed RNA polymerase stimulant | 0.406 0.001 DBMET00851 0.249 0.002 DBMET00674 | DBMET00851 | |
| 0.34 | 0.13 | 0.34 | Cyclophilin D inhibitor | 0.258 0.204 DBMET00674 | ||
| 0.286 | 0.084 | 0.406 | Interleukin 2 agonist | 0.406 0.026 DBMET00851 0.384 0.032 DBMET00674 | DBMET00851 | |
| 0.204 | 0.012 | 0.36 | Interleukin 8 antagonist | 0.36 0.004 DBMET00851 0.125 0.055 DBMET00674 | DBMET00851 | |
| 0.198 | 0.01 | 0.198 | GABA A receptor agonist | 0.097 0.04 DBMET00851 | ||
| 0.21 | 0.034 | 0.21 | Tubulin antagonist | |||
| 0.209 | 0.038 | 0.339 | Lipid peroxidase inhibitor | 0.339 0.014 DBMET00851 0.244 0.028 DBMET00674 | DBMET00851 | |
| 0.161 | 0.002 | 0.303 | Glucocorticoid agonist | 0.303 0.002 DBMET00851 0.162 0.002 DBMET00674 | DBMET00851 | |
| 0.167 | 0.016 | 0.268 | Prolactin inhibitor | 0.268 0.004 DBMET00851 0.23 0.005 DBMET00674 | DBMET00851 | |
| 0.177 | 0.031 | 0.177 | Acetylcholine muscarinic antagonist | 0.108 0.081 DBMET00851 | ||
| 0.146 | 0.004 | 0.182 | Estrone sulfatase inhibitor | 0.182 0.002 DBMET00851 0.153 0.003 DBMET00674 | DBMET00851 | |
| 0.133 | 0.002 | 0.16 | Lipocortins synthesis agonist | 0.16 0.001 DBMET00851 0.136 0.002 DBMET00674 | DBMET00851 | |
| 0.179 | 0.051 | 0.403 | NOS3 expression enhancer | 0.403 0.008 DBMET00851 0.238 0.029 DBMET00674 | DBMET00851 | |
| 0.181 | 0.053 | 0.656 | Diuretic | 0.656 0.004 DBMET00851 0.3 0.022 DBMET00674 | DBMET00851 | |
| 0.133 | 0.008 | 0.358 | 5-Alpha-reductase inhibitor | 0.358 0.002 DBMET00851 0.312 0.003 DBMET00674 | DBMET00851 | |
| 0.199 | 0.077 | 0.264 | Neurotrophic factor enhancer | 0.264 0.031 DBMET00851 0.261 0.033 DBMET00674 | DBMET00851 | |
| 0.138 | 0.024 | 0.138 | Acetylcholine nicotinic antagonist | 0.122 0.029 DBMET00851 0.072 0.065 DBMET00674 | ||
| 0.126 | 0.012 | 0.162 | GABA receptor antagonist | 0.162 0.008 DBMET00851 | DBMET00851 | |
| 0.17 | 0.061 | 0.17 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.123 | 0.015 | 0.14 | Na+ K+ transporting ATPase inhibitor | 0.14 0.008 DBMET00851 0.134 0.01 DBMET00674 | DBMET00851 | |
| 0.155 | 0.047 | 0.239 | Farnesoid X receptor antagonist | 0.239 0.013 DBMET00851 0.166 0.038 DBMET00674 | DBMET00851 | |
| 0.3 | 0.193 | 0.553 | Caspase 9 stimulant | 0.553 0.044 DBMET00851 0.494 0.062 DBMET00674 | DBMET00851 | |
| 0.117 | 0.013 | 0.142 | GABA A receptor antagonist | 0.142 0.01 DBMET00851 | DBMET00851 | |
| 0.112 | 0.007 | 0.577 | Aldosterone antagonist | 0.577 0.001 DBMET00851 0.33 0.003 DBMET00674 | DBMET00851 | |
| 0.115 | 0.014 | 0.171 | Glycine receptor agonist | 0.171 0.005 DBMET00851 0.12 0.012 DBMET00674 | DBMET00851 | |
| 0.102 | 0.018 | 0.102 | Acetylcholine M3 receptor antagonist | |||
| 0.074 | 0.002 | 0.122 | Corticosteroid-like | 0.122 0.001 DBMET00851 0.08 0.002 DBMET00674 | DBMET00851 | |
| 0.098 | 0.034 | 0.18 | Glycine receptor antagonist | 0.18 0.004 DBMET00851 0.131 0.013 DBMET00674 | DBMET00851 | |
| 0.161 | 0.098 | 0.277 | Hepatoprotectant | 0.262 0.04 DBMET00851 0.277 0.036 DBMET00674 | DBMET00674 | |
| 0.105 | 0.044 | 0.161 | ABCA1 expression enhancer | 0.11 0.039 DBMET00851 0.161 0.015 DBMET00674 | DBMET00674 | |
| 0.064 | 0.006 | 0.094 | Glucose-6-phosphate dehydrogenase inhibitor | 0.094 0.003 DBMET00851 0.07 0.005 DBMET00674 | DBMET00851 | |
| 0.08 | 0.027 | 0.102 | Adrenaline uptake inhibitor | 0.102 0.018 DBMET00674 | DBMET00674 | |
| 0.118 | 0.069 | 0.344 | DNA polymerase I inhibitor | 0.221 0.022 DBMET00851 0.344 0.008 DBMET00674 | DBMET00674 | |
| 0.069 | 0.027 | 0.09 | Heme oxygenase stimulant | 0.09 0.01 DBMET00851 0.077 0.017 DBMET00674 | DBMET00851 | |
| 0.06 | 0.02 | 0.441 | Estradiol 17 beta-dehydrogenase inhibitor | 0.441 0.002 DBMET00851 0.265 0.004 DBMET00674 | DBMET00851 | |
| 0.06 | 0.029 | 0.067 | Acetylcholine M2 receptor agonist | 0.067 0.021 DBMET00851 0.052 0.04 DBMET00674 | DBMET00851 | |
| 0.108 | 0.078 | 0.282 | Cholesterol synthesis inhibitor | 0.282 0.013 DBMET00851 0.241 0.019 DBMET00674 | DBMET00851 | |
| 0.104 | 0.074 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.101 | 0.075 | 0.455 | Monophenol monooxygenase inhibitor | 0.455 0.009 DBMET00851 0.271 0.021 DBMET00674 | DBMET00851 | |
| 0.025 | 0.003 | 0.205 | Progesterone receptor A antagonist | 0.205 0.001 DBMET00851 0.075 0.002 DBMET00674 | DBMET00851 | |
| 0.075 | 0.055 | 0.194 | Keratolytic | 0.194 0.009 DBMET00851 0.102 0.029 DBMET00674 | DBMET00851 | |
| 0.191 | 0.173 | 0.65 | Cholesterol antagonist | 0.65 0.013 DBMET00851 0.592 0.02 DBMET00674 | DBMET00851 | |
| 0.057 | 0.039 | 0.098 | Pregnane X receptor antagonist | 0.098 0.004 DBMET00851 0.057 0.039 DBMET00674 | DBMET00851 | |
| 0.127 | 0.109 | 0.21 | Pregnane X receptor agonist | 0.21 0.009 DBMET00851 0.138 0.077 DBMET00674 | DBMET00851 | |
| 0.081 | 0.065 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.039 | 0.027 | 0.047 | GABA uptake inhibitor | 0.047 0.018 DBMET00851 0.039 0.027 DBMET00674 | DBMET00851 | |
| 0.022 | 0.01 | 0.044 | Progesterone receptor B antagonist | 0.044 0.003 DBMET00851 0.038 0.004 DBMET00674 | DBMET00851 | |
| 0.078 | 0.069 | 0.135 | Ornithine decarboxylase inhibitor | 0.135 0.016 DBMET00851 0.093 0.052 DBMET00674 | DBMET00851 | |
| 0.152 | 0.145 | 0.338 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.338 0.014 DBMET00851 0.254 0.041 DBMET00674 | DBMET00851 | |
| 0.031 | 0.024 | 0.355 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.355 0.002 DBMET00851 0.087 0.005 DBMET00674 | DBMET00851 | |
| 0.027 | 0.022 | 0.039 | Hedgehog signaling activator | 0.039 0.005 DBMET00851 0.032 0.01 DBMET00674 | DBMET00851 | |
| 0.119 | 0.115 | 0.119 | Protein-tyrosine phosphatase inhibitor | |||
| 0.006 | 0.004 | 0.057 | Transcortin receptor antagonist | 0.057 0.001 DBMET00851 0.033 0.001 DBMET00674 | DBMET00851 | |
| 0.03 | 0.029 | 0.046 | Estrogen-related receptor beta antagonist | 0.046 0.007 DBMET00851 0.038 0.013 DBMET00674 | DBMET00851 | |
| 0.011 | 0.012 | 0.022 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.022 0.002 DBMET00851 0.015 0.005 DBMET00674 | DBMET00851 | |
| 0.015 | 0.022 | 0.207 | 5-Alpha-reductase 2 inhibitor | 0.207 0.003 DBMET00851 0.134 0.004 DBMET00674 | DBMET00851 | |
| 0.133 | 0.144 | 0.316 | P-glycoprotein inhibitor | 0.316 0.026 DBMET00851 0.193 0.069 DBMET00674 | DBMET00851 | |
| 0.01 | 0.022 | 0.206 | 5-Alpha-reductase 1 inhibitor | 0.206 0.003 DBMET00851 0.13 0.004 DBMET00674 | DBMET00851 | |
| 0.018 | 0.037 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 DBMET00851 0.021 0.019 DBMET00674 | DBMET00851 | |
| 0.183 | 0.205 | 0.328 | Apoptosis antagonist | 0.328 0.068 DBMET00851 0.266 0.112 DBMET00674 | DBMET00851 | |
| 0.016 | 0.038 | 0.056 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.056 0.007 DBMET00851 | DBMET00851 | |
| 0.033 | 0.055 | 0.045 | Liver X receptor agonist | 0.045 0.028 DBMET00851 | DBMET00851 | |
| 0.009 | 0.033 | 0.027 | Thyroid hormone alpha antagonist | 0.027 0.005 DBMET00851 | DBMET00851 | |
| 0.011 | 0.037 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DBMET00851 0.019 0.008 DBMET00674 | DBMET00851 | |
| 0.046 | 0.08 | 0.062 | Nitric oxide donor | 0.062 0.045 DBMET00851 | DBMET00851 | |
| 0.063 | 0.098 | 0.155 | Inducible nitric-oxide synthase inhibitor | 0.155 0.015 DBMET00851 | DBMET00851 | |
| 0.037 | 0.077 | 0.165 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.165 0.004 DBMET00851 0.082 0.015 DBMET00674 | DBMET00851 | |
| 0.075 | 0.115 | 0.116 | Bile acid receptor antagonist | 0.116 0.023 DBMET00851 0.093 0.066 DBMET00674 | DBMET00851 | |
| 0.059 | 0.103 | 0.077 | Opioid kappa receptor antagonist | 0.077 0.062 DBMET00851 0.075 0.066 DBMET00674 | DBMET00851 | |
| 0.059 | 0.108 | 0.123 | Antineoplastic alkaloid | 0.123 0.036 DBMET00851 0.103 0.046 DBMET00674 | DBMET00851 | |
| 0.009 | 0.064 | 0.018 | Telomerase stimulant | 0.018 0.011 DBMET00851 | DBMET00851 | |
| 0.148 | 0.207 | 0.3 | DNA synthesis inhibitor | 0.257 0.062 DBMET00851 0.3 0.044 DBMET00674 | DBMET00674 | |
| 0.111 | 0.171 | 0.227 | Interleukin 6 antagonist | 0.227 0.029 DBMET00851 0.14 0.106 DBMET00674 | DBMET00851 | |
| 0.008 | 0.07 | 0.036 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.036 0.01 DBMET00851 | DBMET00851 | |
| 0.036 | 0.107 | 0.114 | Antineoplastic antibiotic | 0.111 0.041 DBMET00851 0.114 0.04 DBMET00674 | DBMET00674 | |
| 0.022 | 0.098 | 0.04 | Liver X receptor alpha agonist | 0.04 0.03 DBMET00851 | DBMET00851 | |
| 0.102 | 0.18 | 0.259 | Melanin inhibitor | 0.259 0.027 DBMET00851 0.164 0.065 DBMET00674 | DBMET00851 | |
| 0.13 | 0.208 | 0.362 | DNA damaging | 0.362 0.038 DBMET00851 0.26 0.075 DBMET00674 | DBMET00851 | |
| 0.067 | 0.163 | 0.145 | Toll-Like receptor 4 antagonist | 0.145 0.024 DBMET00851 0.114 0.05 DBMET00674 | DBMET00851 | |
| 0.112 | 0.228 | 0.264 | Antioxidant | 0.264 0.077 DBMET00851 0.231 0.095 DBMET00674 | DBMET00851 | |
| 0.097 | 0.215 | 0.244 | Hypolipemic | 0.154 0.132 DBMET00851 0.244 0.07 DBMET00674 | DBMET00674 | |
| 0.096 | 0.226 | 0.25 | Non-steroidal antiinflammatory agent | 0.25 0.043 DBMET00851 0.187 0.082 DBMET00674 | DBMET00851 | |
| 0.071 | 0.204 | 0.252 | Angiogenesis stimulant | 0.252 0.069 DBMET00851 0.247 0.071 DBMET00674 | DBMET00851 | |
| 0.101 | 0.264 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.091 DBMET00851 | DBMET00851 | |
| 0.054 | 0.229 | 0.154 | Microtubule formation inhibitor | 0.154 0.036 DBMET00851 0.108 0.077 DBMET00674 | DBMET00851 | |
| 0.048 | 0.223 | 0.146 | Alkylator | 0.146 0.049 DBMET00851 0.146 0.049 DBMET00674 | DBMET00674 | |
| 0.062 | 0.238 | 0.129 | Neurotrophic factor | 0.129 0.082 DBMET00851 | DBMET00851 | |
| 0.139 | 0.318 | 0.291 | Antibacterial | 0.291 0.142 DBMET00674 | DBMET00674 | |
| 0.053 | 0.247 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.061 DBMET00851 | DBMET00851 | |
| 0.076 | 0.28 | 0.167 | Spasmolytic | 0.167 0.148 DBMET00674 | DBMET00674 | |
| 0.105 | 0.31 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.108 DBMET00851 | DBMET00851 | |
| 0.046 | 0.272 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 DBMET00674 | DBMET00674 | |
| 0.042 | 0.287 | 0.171 | Psychostimulant | 0.171 0.099 DBMET00851 | DBMET00851 | |
| 0.025 | 0.274 | 0.223 | Topoisomerase I inhibitor | 0.223 0.021 DBMET00674 | DBMET00674 | |
| 0.044 | 0.333 | 0.163 | Aldehyde dehydrogenase inhibitor | 0.163 0.04 DBMET00851 | DBMET00851 | |
| 0.047 | 0.359 | 0.198 | Immunostimulant | 0.175 0.136 DBMET00851 0.198 0.121 DBMET00674 | DBMET00674 | |
| 0.085 | 0.413 | 0.205 | Immunomodulator | 0.205 0.159 DBMET00851 | DBMET00851 | |
| 0.056 | 0.398 | 0.133 | Adenylate cyclase stimulant | 0.133 0.094 DBMET00851 | DBMET00851 | |
| 0.013 | 0.358 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.061 0.03 DBMET00674 | DBMET00674 | |
| 0.092 | 0.455 | 0.208 | Caspase 3 stimulant | 0.208 0.158 DBMET00674 | DBMET00674 | |
| 0.08 | 0.447 | 0.215 | RNA-directed DNA polymerase inhibitor | 0.206 0.092 DBMET00851 0.215 0.08 DBMET00674 | DBMET00674 | |
| 0.052 | 0.43 | 0.181 | Sigma receptor agonist | 0.181 0.068 DBMET00674 | DBMET00674 | |
| 0.027 | 0.469 | 0.103 | Amylase inhibitor | 0.103 0.094 DBMET00674 | DBMET00674 | |
| 0.026 | 0.511 | 0.096 | Adenylate cyclase inhibitor | 0.096 0.088 DBMET00851 | DBMET00851 | |
| 0.033 | 0.578 | 0.198 | Interleukin agonist | 0.198 0.122 DBMET00851 | DBMET00851 | |
| 0.033 | 0.579 | 0.226 | 15-Lipoxygenase inhibitor | 0.226 0.186 DBMET00851 | DBMET00851 | |
| 0.061 | 0.868 | 0.231 | Calcium channel L-type activator | 0.231 0.228 DBMET00674 | DBMET00674 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |